Urinalysis Market - Global Forecast To 2029
| 出版 | MarketsandMarkets |
| 出版年月 | 2024年6月 |
| ページ数 | 373 |
| 図表数 | 532 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The urinalysis market is valued at an estimated USD 4.3 billion in 2024 and is projected to reach USD 6.8 billion by 2029 at a CAGR of 9.6% during the forecast period.
尿検査市場は、2024 年に推定 43 億米ドルと評価され、予測期間中に 9.6% の CAGR で 2029 年までに 68 億米ドルに達すると予測されています。
Due to rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes and liver & kidney diseases is expected to increase significantly. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for the basic metabolic panel, lipid profile, and liver & renal panel tests. These tests are performed by urinalysis analyzers, thereby positively impacting market growth. The global rise in the geriatric population is considered a key factor in driving the growth of the urinalysis market.
“Consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period.”
Based on product, the urinalysis market is bifurcated into consumables and instruments. The consumables segment in the urinalysis market is experiencing substantial growth. The recurrent requirement and purchase of these consumables is one of the primary reasons for the high growth rate of this market segment. Also, the wider range of consumables available in the market for urinalysis is contributing significantly to its larger share. The urinalysis market offers variety of consumables catering to different testing needs. Development of new dipsticks with more test parameters will further increase their demand in future.
“Disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period.”
The urinalysis market is bifurcated into disease screening and pregnancy & fertility testing. Disease screening segment is expected to account for the highest CAGR during the forecast period. As urinalysis plays an integral role in diagnosing such diseases, the urinalysis market for disease screening applications is expected to grow in the coming years. Additionally, many conditions detectable through urinalysis, such as early-stage kidney disease and diabetes, often do not exhibit symptoms until they are advanced. Regular urinalysis enables early detection and intervention, which can significantly improve patient outcomes and reduce long-term healthcare costs. This will bolster the extensive use of urinalysis in disease screening, ensuring its position as the largest segment in the market.
“Asia Pacific: The fastest-growing region in urinalysis market.”
The worldwide market for urinalysis is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is poised to experience the most notable CAGR within the urinalysis market. The high growth in the Asia Pacific can be attributed to the increasing government efforts to increase awareness about early disease detection, growing per capita income, the expansion of private-sector hospitals to rural areas in various Asia Pacific countries, and the presence of high-growth markets in the region.
The break-up of the profile of primary participants in the urinalysis market:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in this market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), Danaher (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), QuidelOrtho Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics Holdings plc (UK), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Co., Ltd. (China), DIRUI INDUSTRIAL CO., LTD. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), Erba Mannheim (UK), Alphatec Scientific E.I.R.L. (Peru), Teco Diagnostics (US), Analyticon Biotechnologies GmbH (Germany), Bioway Biological Technology Co., Ltd. (China), High Technology, Inc. (US), Agappe Diagnostics Ltd. (India), TOYOBO CO., LTD. (Japan), DIALAB GmbH (Austria), Quantimetrix (US), BioCare Corporation (Taiwan), Randox Laboratories Ltd. (Ireland), PZ Cormay S.A. (Poland), YD Diagnostics (South Korea), CONTEC MEDICAL SYSTEMS CO., LTD. (China), and Biopanda Reagents Ltd. (UK).
Research Coverage:
This research report categorizes the urinalysis market by product (Consumables [Pregnancy & Fertility Kits, Dipsticks, Disposables, Reagents], Instruments [Automated Urine Analyzers {Integrated Urine Analyzers, Sediment Urine Analyzers (Microscopy Analyzers, Flow Cytometry Analyzers), Biochemical Urine Analyzers, Semi-automated Urine Analyzers}, and Point-of-care Urine Analyzers], by test type (Pregnancy & Fertility Tests, Biochemical Tests [Laboratory Tests, PoC Tests], and Sediment Urinalysis), by application (Disease Screening [Urinary Tract Infections, Kidney Diseases, Diabetes, Liver Diseases, and Other Disease Screening Applications] and Pregnancy & Fertility Testing), by end user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the urinalysis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urinalysis market. Competitive analysis of upcoming startups in the urinalysis market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urinalysis market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer, rising geriatric population and subsequent increase in age-associated diseases, and increasing adoption of PoC urine diagnostic tests), opportunities (Growth opportunities in emerging countries, technological advancements in urine analyzers, and increasing government initiatives and funding for preventive care), restraints (Availability of refurbished urine analyzers and high capital investments and lack of skilled laboratory technicians), and challenges (Changing regulatory landscape) influencing the growth of the urinalysis market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urinalysis market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the urinalysis market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), and Danaher (US).
Table of Contents
1 INTRODUCTION 52
1.1 STUDY OBJECTIVES 52
1.2 MARKET DEFINITION 52
1.3 INCLUSIONS & EXCLUSIONS OF STUDY 53
1.4 STUDY SCOPE 54
1.4.1 MARKET SEGMENTATION 54
1.4.2 REGIONS COVERED 54
1.4.3 YEARS CONSIDERED 55
1.4.4 CURRENCY CONSIDERED 55
1.5 RESEARCH LIMITATIONS 55
1.6 STAKEHOLDERS 56
1.7 SUMMARY OF CHANGES 56
1.8 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
2.2 RESEARCH APPROACH 57
FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY 57
2.2.1 SECONDARY DATA 58
2.2.1.1 Key data from secondary sources 58
2.2.2 PRIMARY DATA 59
2.2.2.1 Primary sources 60
2.2.2.2 Key data from primary sources 60
2.2.2.3 Key industry insights 62
2.2.2.4 Breakdown of primary interviews 62
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 62
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 63
2.3 MARKET SIZE ESTIMATION 63
2.3.1 BOTTOM-UP APPROACH 64
2.3.1.1 Approach 1: Company revenue estimation approach 64
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 64
2.3.1.2 Approach 2: Presentations of companies and primary interviews 64
2.3.1.3 Growth forecast 65
2.3.1.4 CAGR projections 65
FIGURE 5 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 65
2.3.2 TOP-DOWN APPROACH 65
FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH 66
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 67
FIGURE 7 DATA TRIANGULATION METHODOLOGY 67
2.5 MARKET SHARE 68
2.6 STUDY ASSUMPTIONS 68
2.7 GROWTH RATE ASSUMPTIONS 68
2.8 RISK ASSESSMENT 69
2.8.1 URINALYSIS MARKET: RISK ASSESSMENT 69
2.9 RECESSION IMPACT 69
3 EXECUTIVE SUMMARY 71
FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 71
FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2024 VS. 2029 (USD MILLION) 72
FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 72
FIGURE 11 URINALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 73
FIGURE 12 URINALYSIS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 74
4 PREMIUM INSIGHTS 75
4.1 URINALYSIS MARKET OVERVIEW 75
FIGURE 13 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH 75
4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2024 VS. 2029 76
FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE URINALYSIS PRODUCTS MARKET 76
4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2024 VS. 2029 76
FIGURE 15 PREGNANCY & FERTILITY TESTS SEGMENT TO DOMINATE MARKET 76
4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2024 VS. 2029 77
FIGURE 16 DISEASE SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 77
4.5 URINALYSIS MARKET SHARE, BY END USER, 2024 VS. 2029 77
FIGURE 17 DIAGNOSTIC LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024 77
4.6 URINALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 78
FIGURE 18 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 78
5 MARKET OVERVIEW 79
5.1 INTRODUCTION 79
5.2 MARKET DYNAMICS 79
FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 79
5.2.1 DRIVERS 80
5.2.1.1 Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer 80
TABLE 1 ESTIMATED NUMBER OF ADULTS (20–79 YEARS) WITH DIABETES WORLDWIDE, BY REGION, 2021 VS. 2030 VS. 2045 81
5.2.1.2 Rising geriatric population and subsequent increase in age-associated diseases 81
TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER, BY REGION, 2022 VS. 2030 VS. 2050 82
5.2.1.3 Increasing adoption of PoC urine diagnostic tests 82
5.2.2 RESTRAINTS 83
5.2.2.1 Availability of refurbished urine analyzers 83
5.2.2.2 High capital investments and lack of skilled laboratory technicians 83
5.2.3 OPPORTUNITIES 83
5.2.3.1 Growth opportunities in emerging countries 83
5.2.3.2 Technological advancements in urine analyzers 84
5.2.3.3 Increasing government initiatives and funding for preventive care 84
5.2.4 CHALLENGES 85
5.2.4.1 Changing regulatory landscape 85
5.3 PRICING ANALYSIS 85
TABLE 3 INDICATIVE PRICING FOR URINALYSIS PRODUCTS 86
TABLE 4 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY REGION 86
5.4 PATENT ANALYSIS 88
FIGURE 20 PATENT ANALYSIS FOR FLOW CYTOMETRY (JANUARY 2014–DECEMBER 2023) 88
5.4.1 LIST OF MAJOR PATENTS 89
5.5 VALUE CHAIN ANALYSIS 90
FIGURE 21 VALUE CHAIN ANALYSIS OF URINALYSIS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 91
5.6 SUPPLY CHAIN ANALYSIS 92
FIGURE 22 URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS 93
5.7 TRADE ANALYSIS 93
5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS 93
TABLE 5 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION) 93
TABLE 6 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION) 94
5.8 ECOSYSTEM ANALYSIS 94
FIGURE 23 URINALYSIS MARKET: ECOSYSTEM ANALYSIS 95
5.8.1 URINALYSIS MARKET: ROLE IN ECOSYSTEM 95
5.9 PORTER’S FIVE FORCES ANALYSIS 96
FIGURE 24 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 96
TABLE 7 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 97
5.9.1 THREAT OF NEW ENTRANTS 97
5.9.2 THREAT OF SUBSTITUTES 97
5.9.3 BARGAINING POWER OF BUYERS 97
5.9.4 BARGAINING POWER OF SUPPLIERS 97
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.10 REGULATORY LANDSCAPE 98
5.10.1 NORTH AMERICA 98
5.10.1.1 US 98
5.10.1.2 Canada 98
5.10.2 EUROPE 98
TABLE 8 EUROPE: CLASSIFICATION OF DEVICES 99
5.10.3 ASIA PACIFIC 99
5.10.3.1 China 99
5.10.3.2 Japan 99
TABLE 9 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 100
5.10.3.3 India 100
5.10.4 LATIN AMERICA 100
5.10.4.1 Brazil 100
5.10.4.2 Mexico 101
5.10.5 MIDDLE EAST 101
5.10.5.1 Africa 101
5.10.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
5.11 TECHNOLOGY ANALYSIS 103
5.11.1 KEY TECHNOLOGY 103
5.11.1.1 Automated urine analyzers 103
5.11.2 COMPLEMENTARY TECHNOLOGY 104
5.11.2.1 Point-of-care urine analyzers 104
5.11.3 ADJACENT TECHNOLOGY 104
5.11.3.1 Multiplex PCR 104
5.12 KEY CONFERENCES & EVENTS IN 2024–2025 105
TABLE 15 URINALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 105
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 106
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS MARKET 106
FIGURE 25 REVENUE SHIFT IN URINALYSIS MARKET 106
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 107
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 107
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS 107
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF URINALYSIS PRODUCTS (%) 107
5.14.2 BUYING CRITERIA 107
FIGURE 27 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS 107
TABLE 17 KEY BUYING CRITERIA FOR URINALYSIS PRODUCTS 108
5.15 INVESTMENT & FUNDING SCENARIO 108
FIGURE 28 URINALYSIS MARKET: INVESTMENT & FUNDING SCENARIO 108
5.16 CASE STUDY ANALYSIS 109
5.17 IMPACT OF ARTIFICIAL INTELLIGENCE ON URINALYSIS MARKET 109
6 URINALYSIS MARKET, BY PRODUCT 112
6.1 INTRODUCTION 113
TABLE 18 URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 113
6.1.1 PRIMARY NOTES 113
6.1.1.1 Key industry insights 113
6.2 CONSUMABLES 114
TABLE 19 KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET 114
TABLE 20 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 115
TABLE 21 URINALYSIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 115
TABLE 22 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 23 EUROPE: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 24 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 25 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
6.2.1 PREGNANCY & FERTILITY KITS 117
6.2.1.1 Rapid accessibility and testing convenience to drive market 117
TABLE 26 KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET 118
TABLE 27 PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 118
TABLE 28 NORTH AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 29 EUROPE: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 30 ASIA PACIFIC: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 31 LATIN AMERICA: PREGNANCY & FERTILITY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120
6.2.2 DIPSTICKS 120
6.2.2.1 Low cost to increase adoption 120
TABLE 32 KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET 121
TABLE 33 DIPSTICKS MARKET, BY REGION, 2022–2029 (USD MILLION) 121
TABLE 34 NORTH AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 35 EUROPE: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 36 ASIA PACIFIC: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 37 LATIN AMERICA: DIPSTICKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122
6.2.3 REAGENTS 123
6.2.3.1 Increasing use of controls and calibrators to drive market 123
TABLE 38 KEY PRODUCTS IN URINALYSIS REAGENTS MARKET 123
TABLE 39 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 123
TABLE 40 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 41 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 42 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 43 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
6.2.4 DISPOSABLES 125
6.2.4.1 Wise usage in hospitals and clinical laboratories to support market growth 125
TABLE 44 DISPOSABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 126
TABLE 45 NORTH AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 46 EUROPE: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 47 ASIA PACIFIC: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 48 LATIN AMERICA: DISPOSABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127
6.3 INSTRUMENTS 127
TABLE 49 KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET 128
TABLE 50 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 128
TABLE 51 URINALYSIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 52 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 53 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 54 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130
TABLE 55 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130
6.3.1 AUTOMATED URINE ANALYZERS 130
TABLE 56 KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET 131
TABLE 57 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 131
TABLE 58 AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 131
TABLE 59 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 60 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 61 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 62 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
6.3.1.1 Integrated urine analyzers 133
6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers 133
TABLE 63 KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET 134
TABLE 64 INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 134
TABLE 65 NORTH AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 66 EUROPE: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 67 ASIA PACIFIC: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 68 LATIN AMERICA: INTEGRATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
6.3.1.2 Sediment urine analyzers 136
TABLE 69 KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET 136
TABLE 70 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 136
TABLE 71 SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 137
TABLE 72 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 73 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 74 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 75 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139
6.3.1.2.1 Flow cytometry analyzers 139
6.3.1.2.1.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption 139
TABLE 76 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 139
TABLE 77 NORTH AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 78 EUROPE: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 79 ASIA PACIFIC: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 80 LATIN AMERICA: FLOW CYTOMETRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.3.1.2.2 Microscopy analyzers 141
6.3.1.2.2.1 Increased speed and accuracy of analysis to drive adoption 141
TABLE 81 MICROSCOPY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 82 NORTH AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 83 EUROPE: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 84 ASIA PACIFIC: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 85 LATIN AMERICA: MICROSCOPY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
6.3.1.3 Biochemical urine analyzers 143
6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market 143
TABLE 86 KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET 144
TABLE 87 BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 88 NORTH AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 89 EUROPE: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 90 ASIA PACIFIC: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 91 LATIN AMERICA: BIOCHEMICAL URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
6.3.2 SEMI-AUTOMATED URINE ANALYZERS 146
6.3.2.1 Extensive use in hospitals & clinics to drive segment growth 146
TABLE 92 KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET 146
TABLE 93 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 147
TABLE 94 NORTH AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 95 EUROPE: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 96 ASIA PACIFIC: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 97 LATIN AMERICA: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
6.3.3 POINT-OF-CARE URINE ANALYZERS 149
6.3.3.1 Need for rapid testing to drive demand for PoC urine analyzers 149
TABLE 98 KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET 149
TABLE 99 POC URINE ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 150
TABLE 100 NORTH AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 101 EUROPE: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 102 ASIA PACIFIC: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 103 LATIN AMERICA: POC URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
7 URINALYSIS MARKET, BY TEST TYPE 152
7.1 INTRODUCTION 153
TABLE 104 URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 153
7.1.1 PRIMARY NOTES 153
7.1.1.1 Key industry insights 153
7.2 PREGNANCY & FERTILITY TESTS 154
7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET 154
TABLE 105 KEY PRODUCTS IN PREGNANCY & FERTILITY TESTS MARKET 155
TABLE 106 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2022–2029 (USD MILLION) 155
TABLE 107 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 108 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 109 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 110 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 157
7.3 BIOCHEMICAL TESTS 157
TABLE 111 KEY PRODUCTS IN BIOCHEMICAL TESTS MARKET 158
TABLE 112 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 158
TABLE 113 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 114 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 115 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 116 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 117 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 160
7.3.1 LABORATORY TESTS 160
7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market 160
TABLE 118 KEY PRODUCTS IN LABORATORY TESTS MARKET 161
TABLE 119 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2022–2029 (USD MILLION) 161
TABLE 120 NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 121 EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 122 ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 123 LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 163
7.3.2 POC TESTS 163
7.3.2.1 Convenience of PoC testing to drive segment growth 163
TABLE 124 KEY PRODUCTS IN POC TESTS MARKET 163
TABLE 125 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2022–2029 (USD MILLION) 164
TABLE 126 NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 127 EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 128 ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 129 LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2022–2029 (USD MILLION) 166
7.4 SEDIMENT URINALYSIS 166
7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET 166
TABLE 130 KEY PRODUCTS IN SEDIMENT URINALYSIS MARKET 166
TABLE 131 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2022–2029 (USD MILLION) 167
TABLE 132 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 133 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 134 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 135 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2022–2029 (USD MILLION) 169
8 URINALYSIS MARKET, BY APPLICATION 170
8.1 INTRODUCTION 171
TABLE 136 URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 171
8.1.1 PRIMARY NOTES 171
8.1.1.1 Key industry insights 171
8.2 DISEASE SCREENING 172
TABLE 137 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 138 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 139 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 140 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 141 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 142 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2022–2029 (USD MILLION) 175
8.2.1 URINARY TRACT INFECTIONS 175
8.2.1.1 Increasing prevalence of UTIs to drive segment growth 175
TABLE 143 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2022–2029 (USD MILLION) 176
TABLE 144 NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 145 EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 146 ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 147 LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 178
8.2.2 KIDNEY DISEASES 178
8.2.2.1 Rapidly growing geriatric population and increasing prevalence of kidney diseases to fuel segment growth 178
TABLE 148 TOTAL GERIATRIC POPULATION, 2022 VS. 2030 VS. 2050 (%) 179
TABLE 149 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2022–2029 (USD MILLION) 179
TABLE 150 NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 151 EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 152 ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 153 LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 181
8.2.3 DIABETES 181
8.2.3.1 Development of advanced analytical tools to drive market 181
TABLE 154 ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION) 182
TABLE 155 TOP TEN COUNTRIES/TERRITORIES WITH HIGHEST TOTAL HEALTH EXPENDITURE (USD) DUE TO DIABETES IN 2021, 20–79 YEARS (USD BILLION) 182
TABLE 156 URINALYSIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION) 183
TABLE 157 NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 158 EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 159 ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 160 LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 184
8.2.4 LIVER DISEASES 184
8.2.4.1 High prevalence of liver diseases to support market growth 184
TABLE 161 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2022–2029 (USD MILLION) 185
TABLE 162 NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 163 EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 164 ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 165 LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 187
8.2.5 OTHER DISEASE SCREENING APPLICATIONS 187
TABLE 166 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 188
TABLE 167 NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 168 EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 169 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 170 LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 190
8.3 PREGNANCY & FERTILITY TESTING 190
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT 190
TABLE 171 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2022–2029 (USD MILLION) 191
TABLE 172 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 173 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 174 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 175 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2022–2029 (USD MILLION) 193
9 URINALYSIS MARKET, BY END USER 194
9.1 INTRODUCTION 195
TABLE 176 URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 195
9.2 DIAGNOSTIC LABORATORIES 195
9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET 195
TABLE 177 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 196
TABLE 178 NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 179 EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 180 ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 181 LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 198
9.3 HOSPITALS & CLINICS 198
9.3.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH 198
TABLE 182 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION) 199
TABLE 183 NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 184 EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 185 ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 186 LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 201
9.4 HOME CARE SETTINGS 201
9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET 201
TABLE 187 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION) 202
TABLE 188 NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 189 EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 203
TABLE 190 ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 203
TABLE 191 LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 204
9.5 RESEARCH LABORATORIES & INSTITUTES 204
9.5.1 DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET 204
TABLE 192 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 205
TABLE 193 NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 194 EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 195 ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 196 LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 207
10 URINALYSIS MARKET, BY REGION 208
10.1 INTRODUCTION 209
TABLE 197 URINALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION) 209
10.2 NORTH AMERICA 209
FIGURE 29 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT 210
TABLE 198 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 199 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 211
TABLE 200 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 201 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 202 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 203 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 204 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 213
TABLE 205 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 206 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 213
TABLE 207 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 208 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 214
10.2.1 NORTH AMERICA: RECESSION IMPACT 214
10.2.2 US 215
10.2.2.1 Rising prevalence of chronic diseases to drive market 215
TABLE 209 US: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 216
TABLE 210 US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 211 US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 212 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 213 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 214 US: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 217
TABLE 215 US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 216 US: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 218
TABLE 217 US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 218 US: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 219
10.2.3 CANADA 219
10.2.3.1 Rising burden of CKD to augment market 219
TABLE 219 CANADA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 220
TABLE 220 CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 221 CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 222 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 223 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 224 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 221
TABLE 225 CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 226 CANADA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 222
TABLE 227 CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 228 CANADA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 223
10.3 EUROPE 223
TABLE 229 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 224
TABLE 230 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 224
TABLE 231 EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 232 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 233 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 234 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 235 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 226
TABLE 236 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 237 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 227
TABLE 238 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 239 EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 227
10.3.1 EUROPE: RECESSION IMPACT 228
10.3.2 GERMANY 228
10.3.2.1 Increasing healthcare expenditure to fuel market growth 228
TABLE 240 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 229
TABLE 241 GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 242 GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 243 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 244 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 245 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 230
TABLE 246 GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 247 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 231
TABLE 248 GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 249 GERMANY: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 232
10.3.3 UK 232
10.3.3.1 Rising government healthcare expenditure to propel market 232
TABLE 250 UK: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 233
TABLE 251 UK: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 252 UK: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 253 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 254 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 255 UK: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 234
TABLE 256 UK: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 257 UK: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 235
TABLE 258 UK: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 259 UK: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 236
10.3.4 FRANCE 236
10.3.4.1 High R&D expenditure to provide growth opportunities 236
TABLE 260 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 237
TABLE 261 FRANCE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 262 FRANCE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 263 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 238
TABLE 264 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 238
TABLE 265 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 238
TABLE 266 FRANCE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 267 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 239
TABLE 268 FRANCE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 269 FRANCE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 240
10.3.5 ITALY 240
10.3.5.1 Rising prevalence of diabetes to drive market 240
TABLE 270 ITALY: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 241
TABLE 271 ITALY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 272 ITALY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 273 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 274 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 275 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 242
TABLE 276 ITALY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 277 ITALY: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 243
TABLE 278 ITALY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 279 ITALY: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 244
10.3.6 SPAIN 244
10.3.6.1 Growing elderly population to propel market 244
TABLE 280 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 245
TABLE 281 SPAIN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 282 SPAIN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 283 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 284 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 285 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 246
TABLE 286 SPAIN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 287 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 247
TABLE 288 SPAIN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 289 SPAIN: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 248
10.3.7 RUSSIA 248
10.3.7.1 Long-term healthcare investment initiatives by government to support market growth 248
TABLE 290 RUSSIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 249
TABLE 291 RUSSIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 292 RUSSIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 293 RUSSIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 250
TABLE 294 RUSSIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 250
TABLE 295 RUSSIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 250
TABLE 296 RUSSIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 297 RUSSIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 251
TABLE 298 RUSSIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 299 RUSSIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 252
10.3.8 REST OF EUROPE 252
TABLE 300 DEATHS DUE TO KIDNEY DISEASES PER 100,000 POPULATION, BY COUNTRY, 2020 253
TABLE 301 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 253
TABLE 302 REST OF EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 303 REST OF EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 304 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 305 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 255
TABLE 306 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 255
TABLE 307 REST OF EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 255
TABLE 308 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 256
TABLE 309 REST OF EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 256
TABLE 310 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 256
10.4 ASIA PACIFIC 257
FIGURE 30 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT 258
TABLE 311 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 259
TABLE 312 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 259
TABLE 313 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 259
TABLE 314 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 315 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 316 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 317 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 261
TABLE 318 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 261
TABLE 319 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 261
TABLE 320 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 321 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 262
10.4.1 ASIA PACIFIC: RECESSION IMPACT 262
10.4.2 CHINA 263
10.4.2.1 Improving healthcare infrastructure to support market growth 263
TABLE 322 CHINA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 264
TABLE 323 CHINA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 264
TABLE 324 CHINA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 264
TABLE 325 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 265
TABLE 326 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 265
TABLE 327 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 265
TABLE 328 CHINA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 266
TABLE 329 CHINA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 266
TABLE 330 CHINA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 266
TABLE 331 CHINA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 267
10.4.3 JAPAN 267
10.4.3.1 Favorable regulatory framework to drive market growth 267
TABLE 332 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 268
TABLE 333 JAPAN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 269
TABLE 334 JAPAN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 269
TABLE 335 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 269
TABLE 336 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 270
TABLE 337 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 270
TABLE 338 JAPAN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 270
TABLE 339 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 271
TABLE 340 JAPAN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 271
TABLE 341 JAPAN: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 271
10.4.4 INDIA 272
10.4.4.1 Increasing investments in healthcare system to drive market 272
TABLE 342 INDIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 272
TABLE 343 INDIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 273
TABLE 344 INDIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 273
TABLE 345 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 273
TABLE 346 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 274
TABLE 347 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 274
TABLE 348 INDIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 274
TABLE 349 INDIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 275
TABLE 350 INDIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 275
TABLE 351 INDIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 275
10.4.5 AUSTRALIA 276
10.4.5.1 Rising prevalence of chronic diseases to propel market 276
TABLE 352 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 276
TABLE 353 AUSTRALIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 276
TABLE 354 AUSTRALIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 355 AUSTRALIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 356 AUSTRALIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 357 AUSTRALIA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 278
TABLE 358 AUSTRALIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 278
TABLE 359 AUSTRALIA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 278
TABLE 360 AUSTRALIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 279
TABLE 361 AUSTRALIA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 279
10.4.6 SOUTH KOREA 279
10.4.6.1 Growing medical tourism to drive demand for urinalysis 279
TABLE 362 SOUTH KOREA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 280
TABLE 363 SOUTH KOREA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 364 SOUTH KOREA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 365 SOUTH KOREA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 366 SOUTH KOREA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 367 SOUTH KOREA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 282
TABLE 368 SOUTH KOREA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 282
TABLE 369 SOUTH KOREA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 282
TABLE 370 SOUTH KOREA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 283
TABLE 371 SOUTH KOREA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 283
10.4.7 REST OF ASIA PACIFIC 283
TABLE 372 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 284
TABLE 373 REST OF ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 285
TABLE 374 REST OF ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 285
TABLE 375 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 285
TABLE 376 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 377 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 286
TABLE 378 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 379 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 287
TABLE 380 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 287
TABLE 381 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 287
10.5 LATIN AMERICA 288
TABLE 382 LATIN AMERICA: URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 289
TABLE 383 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 289
TABLE 384 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 290
TABLE 385 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 290
TABLE 386 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 290
TABLE 387 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 388 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 291
TABLE 389 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 390 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 292
TABLE 391 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 292
TABLE 392 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 292
10.5.1 LATIN AMERICA: RECESSION IMPACT 293
10.5.2 BRAZIL 293
10.5.2.1 Largest healthcare market in Latin America 293
TABLE 393 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 293
TABLE 394 BRAZIL: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 395 BRAZIL: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 396 BRAZIL: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 397 BRAZIL: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 295
TABLE 398 BRAZIL: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 295
TABLE 399 BRAZIL: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 295
TABLE 400 BRAZIL: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 296
TABLE 401 BRAZIL: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 296
TABLE 402 BRAZIL: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 296
10.5.3 MEXICO 297
10.5.3.1 Popularity in medical tourism to drive market growth 297
TABLE 403 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 297
TABLE 404 MEXICO: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 298
TABLE 405 MEXICO: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 298
TABLE 406 MEXICO: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 298
TABLE 407 MEXICO: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 299
TABLE 408 MEXICO: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 299
TABLE 409 MEXICO: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 299
TABLE 410 MEXICO: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 300
TABLE 411 MEXICO: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 300
TABLE 412 MEXICO: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 300
10.5.4 REST OF LATIN AMERICA 301
TABLE 413 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 301
TABLE 414 REST OF LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 302
TABLE 415 REST OF LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 302
TABLE 416 REST OF LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 302
TABLE 417 REST OF LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 303
TABLE 418 REST OF LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 303
TABLE 419 REST OF LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 303
TABLE 420 REST OF LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 304
TABLE 421 REST OF LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 304
TABLE 422 REST OF LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 304
10.6 MIDDLE EAST & AFRICA 305
10.6.1 UNFAVORABLE REIMBURSEMENT POLICIES TO RESTRAIN MARKET GROWTH 305
TABLE 423 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 305
TABLE 424 MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 306
TABLE 425 MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 306
TABLE 426 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 306
TABLE 427 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 307
TABLE 428 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 307
TABLE 429 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 307
TABLE 430 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 308
TABLE 431 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 308
TABLE 432 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 308
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 309
10.7 GCC COUNTRIES 309
10.7.1 RISING HEALTHCARE EXPENDITURE AND SUPPORTIVE GOVERNMENT INITIATIVES TO PROPEL MARKET 309
TABLE 433 GCC COUNTRIES: URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 310
TABLE 434 GCC COUNTRIES: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 310
TABLE 435 GCC COUNTRIES: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 310
TABLE 436 GCC COUNTRIES: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 311
TABLE 437 GCC COUNTRIES: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 311
TABLE 438 GCC COUNTRIES: URINALYSIS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION) 311
TABLE 439 GCC COUNTRIES: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2022–2029 (USD MILLION) 312
TABLE 440 GCC COUNTRIES: URINALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 312
TABLE 441 GCC COUNTRIES: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2022–2029 (USD MILLION) 312
TABLE 442 GCC COUNTRIES: URINALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 313
10.7.2 GCC COUNTRIES: RECESSION IMPACT 313
11 COMPETITIVE LANDSCAPE 314
11.1 OVERVIEW 314
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 314
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN URINALYSIS MARKET 315
TABLE 443 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 315
11.3 REVENUE ANALYSIS 316
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET, 2021–2023 (USD MILLION) 316
11.4 MARKET SHARE ANALYSIS 317
FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET (2023) 317
TABLE 444 URINALYSIS MARKET: DEGREE OF COMPETITION 318
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 319
11.5.1 STARS 319
11.5.2 EMERGING LEADERS 319
11.5.3 PERVASIVE PLAYERS 319
11.5.4 PARTICIPANTS 320
FIGURE 33 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 320
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 321
11.5.5.1 Company footprint 321
FIGURE 34 URINALYSIS MARKET: COMPANY FOOTPRINT 321
11.5.5.2 Product footprint 322
TABLE 445 URINALYSIS MARKET: PRODUCT FOOTPRINT 322
11.5.5.3 Region footprint 322
TABLE 446 URINALYSIS MARKET: REGION FOOTPRINT 322
11.5.5.4 Application footprint 323
TABLE 447 URINALYSIS MARKET: APPLICATION FOOTPRINT 323
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 324
11.6.1 PROGRESSIVE COMPANIES 324
11.6.2 RESPONSIVE COMPANIES 324
11.6.3 DYNAMIC COMPANIES 324
11.6.4 STARTING BLOCKS 324
FIGURE 35 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 325
11.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, 2023 326
TABLE 448 URINALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 326
TABLE 449 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 326
11.7 VALUATION AND FINANCIAL METRICS OF URINALYSIS VENDORS 327
FIGURE 36 EV/EBITDA OF KEY VENDORS 327
FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 327
11.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 328
FIGURE 38 BRAND/PRODUCT COMPARISON: URINE ANALYZERS 328
11.9 COMPETITIVE SCENARIO 329
11.9.1 PRODUCT LAUNCHES 329
TABLE 450 URINALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 329
11.9.2 DEALS 330
TABLE 451 URINALYSIS MARKET: DEALS, JANUARY 2021–MAY 2024 330
11.9.3 EXPANSIONS 331
TABLE 452 URINALYSIS MARKET: EXPANSIONS, JANUARY 2021–MAY 2024 331
12 COMPANY PROFILES 332
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS 332
12.1.1 SIEMENS HEALTHINEERS AG 332
TABLE 453 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 332
FIGURE 39 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 333
TABLE 454 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 333
TABLE 455 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–MAY 2024 334
TABLE 456 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021–MAY 2024 336
12.1.2 F. HOFFMANN-LA ROCHE LTD. 337
TABLE 457 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 337
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023) 338
TABLE 458 F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERED 338
12.1.3 CARDINAL HEALTH 340
TABLE 459 CARDINAL HEALTH: COMPANY OVERVIEW 340
FIGURE 41 CARDINAL HEALTH: COMPANY SNAPSHOT (2023) 341
TABLE 460 CARDINAL HEALTH: PRODUCTS OFFERED 341
TABLE 461 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021–MAY 2024 342
12.1.4 DANAHER 344
TABLE 462 DANAHER: COMPANY OVERVIEW 344
FIGURE 42 DANAHER: COMPANY SNAPSHOT (2023) 345
TABLE 463 DANAHER: PRODUCTS OFFERED 345
TABLE 464 DANAHER: DEALS, JANUARY 2021–MAY 2024 346
TABLE 465 DANAHER: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2024 346
12.1.5 ABBOTT 347
TABLE 466 ABBOTT: COMPANY OVERVIEW 347
FIGURE 43 ABBOTT: COMPANY SNAPSHOT (2023) 348
TABLE 467 ABBOTT: PRODUCTS OFFERED 348
12.1.6 SYSMEX CORPORATION 351
TABLE 468 SYSMEX CORPORATION: COMPANY OVERVIEW 351
FIGURE 44 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022) 352
TABLE 469 SYSMEX CORPORATION: PRODUCTS OFFERED 352
TABLE 470 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 353
TABLE 471 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2021–MAY 2024 353
12.1.7 THERMO FISHER SCIENTIFIC INC. 354
TABLE 472 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 354
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 355
TABLE 473 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 355
TABLE 474 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–MAY 2024 356
12.1.8 QUIDELORTHO CORPORATION 357
TABLE 475 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 357
FIGURE 46 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023) 358
TABLE 476 QUIDELORTHO CORPORATION: PRODUCTS OFFERED 358
TABLE 477 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–MAY 2024 359
12.1.9 BECTON, DICKINSON AND COMPANY 360
TABLE 478 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 360
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 361
TABLE 479 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 361
12.1.10 BIO-RAD LABORATORIES, INC. 363
TABLE 480 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 363
FIGURE 48 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 364
TABLE 481 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 364
12.1.11 EKF DIAGNOSTICS HOLDINGS PLC 365
TABLE 482 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY OVERVIEW 365
FIGURE 49 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT (2023) 366
TABLE 483 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCTS OFFERED 366
12.2 OTHER PLAYERS 367
12.2.1 ARKRAY, INC. 367
12.2.2 ACON LABORATORIES, INC. 368
12.2.3 77 ELEKTRONIKA KFT. 369
12.2.4 URIT MEDICAL ELECTRONIC CO., LTD. 370
12.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 371
12.2.6 DIRUI INDUSTRIAL CO., LTD. 372
12.2.7 BIOBASE GROUP 373
12.2.8 ERBA MANNHEIM 373
12.2.9 ALPHATEC SCIENTIFIC E.I.R.L. 374
12.2.10 TECO DIAGNOSTICS 374
12.2.11 ANALYTICON BIOTECHNOLOGIES GMBH 375
12.2.12 BIOWAY BIOLOGICAL TECHNOLOGY CO., LTD 376
12.2.13 HIGH TECHNOLOGY, INC. 376
12.2.14 AGAPPE DIAGNOSTICS LTD 377
12.2.15 TOYOBO CO., LTD. 378
12.2.16 DIALAB GMBH 379
12.2.17 QUANTIMETRIX 379
12.2.18 BIOCARE CORPORATION 380
12.2.19 RANDOX LABORATORIES LTD. 380
12.2.20 PZ CORMAY S.A. 381
12.2.21 YD DIAGNOSTICS 381
12.2.22 CONTEC MEDICAL SYSTEMS CO., LTD. 382
12.2.23 BIOPANDA REAGENTS LTD. 382
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 383
13.1 DISCUSSION GUIDE 383
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 387
13.3 CUSTOMIZATION OPTIONS 389
13.4 RELATED REPORTS 389
13.5 AUTHOR DETAILS 390
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価判定を受けているインドに本社をおく市場調査会社です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD10,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後2営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。
最新調査レポート
- CAR-T細胞療法市場 – 2029年までの世界予測 2024-07-22
- ストーンフローリング市場 – 2029年までの世界予測 2024-07-19
- グリーンメタノール市場 – 2030年までの世界予測 2024-07-19
- テトラアセチルエチレンジアミン (TAED) 市場 – 2029年までの世界予測 2024-07-18
- バッテリーTIC（試験・検査・認証）市場 – 2029年までの世界予測 2024-07-18